Nature, Published online: 16 April 2025; doi:10.1038/s41586-025-08834-1A method, RARE-seq, for sensitive detection of cell-free RNAs in blood is demonstrated to have diverse clinical applications including diagnosing and characterizing human cancers, and tracking response to RNA therapeutics.